Amiodarone Hydrochloride

盐酸胺碘酮

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameAmiodarone Hydrochloride
Drug Alias Name羟酸AmiodaronumAmiodarone乙胺碘肤酮盐酸乙胺碘呋酮 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersSodium channel alpha subunit blockersBeta adrenergic receptors antagonists +[5] 
TargetsPotassium channelSodium channel alpha subunitBeta adrenergic receptors +[5] 
Therapy Area/IndicationsRejection of lung transplantationPostoperative ComplicationsHeart Failure +[16] 
Global Approved IndicationsVentricular FibrillationTachycardia, VentricularArrhythmias, Cardiac
Approved Indications in ChinaArrhythmias, Cardiac
Original Approved Country/TerritoryMainland China
Original Approved Date1983/01/01
Country/TerritoryCanadaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health And Science UniversityOhsu Knight Cancer InstituteThe University Of Chicago +[6] 
Inactive CompaniesWyeth LlcNational Institute of Cardiology, Warsaw, PolandWyeth Pharmaceuticals Inc +[9] 
Active IndicationsPostoperative ComplicationsHeart ArrestAtrial Fibrillation +[5] 
Inactive IndicationsRejection of lung transplantationHeart FailureDeath, Sudden, Cardiac +[11] 

Other Information

ATC CodeC01BD01
Related LinksWikipediaDrugBankKEGG